We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The PrEP Impact Trial involved 157 sexual health services and confirms PrEP's real-world effectiveness.
Overview of a national framework to monitor and evaluate the delivery of PrEP in England using STI surveillance data.
A report on using neutralising monoclonal antibodies (nMABs) in a prophylaxis setting for patients with highest-risk of hospitalisation or death from COVID-19.
A roadmap for improving access, uptake and use of HIV pre-exposure prophylaxis (PrEP) among all population groups who could benefit from using PrEP.
Information for local authorities in England about the grant, which will support local authorities to deliver routine commissioning of PrEP in 2020 to 2021.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
New HIV transmissions in England have fallen by almost a third since 2019, according to an update on the HIV Action Plan for England published today.
Professor Susan Hopkins, UKHSA’s Chief Medical Adviser, is calling for more awareness on International Women's Day 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).